Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70251 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Siqi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Drug Resistant Epilepsy, Fluorodeoxyglucose F18, Magnetic Resonance Imaging, Positron-Emission Tomography. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Purpose
Surgery remains the only curative option for a third of refractory epilepsy patients, though success depends on precise localization of the epileptogenic zone (EZ). This study aims to assess the clinical value of hybrid 18 F‐FDG and 18 F‐DPA‐714 PET/MRI for accurate localization and precise boundary delineation.
Methods
The refractory epilepsy patients who underwent surgery at Xuanwu Hospital from November 2022 to November 2023 were retrospectively recruited. Preoperative simultaneous 18 F‐FDG and 18 F‐DPA‐714 PET/MRI imaging were analyzed using the asymmetry index (AI) and a 4‐point visual score, with the surgical site and pathological findings serving as the gold standard.
Results
A total of 43 patients (mean age: 26.30 ± 8.37 years, male: 28) were included in this study. Lesion localization accuracy within the EZ was 76.7% for 18 F‐FDG PET/MRI, 69.8% for 18 F‐DPA‐714 PET/MRI, and 60.5% for conventional MRI ( p = 0.26). In 26 MRI‐positive cases, conventional MRI accurately localized all lesions within the EZ, with three cases showing negative findings on 18 F‐FDG images and six on 18 F‐DPA‐714. Among 17 MRI‐negative patients, thirteen demonstrated positive results on hybrid PET/MRI. Additionally, 18 F‐DPA‐714 PET/MRI proved more effective in delineating lesion boundaries. Compared to 18 F‐FDG, the AI score was significantly lower (0.25 ± 0.18 vs. 0.46 ± 0.19, p < 0.001), while the visual score was higher (4.00 ± 2.00 vs. 3.00 ± 0.00, p = 0.01).
Conclusion
18 F‐DPA‐714 PET/MRI can effectively complement conventional MRI in the preoperative assessment of refractory epilepsy, with localization accuracy on par with 18 F‐FDG and enhanced capability in delineating lesion boundaries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.
- Department of Radiation Oncology, Xuanwu Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Siqi Zhang, Jie Hu, Jie Lu
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Zhang, S., Hu, J., Qi, Z., Yao, C., Cui, B., Wang, J., Wang, Z., & Lu, J. (2025). Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70251
Vancouver
Zhang S, Hu J, Qi Z, Yao C, Cui B, Wang J, et al. Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70251
BibTeX
@article{Zhang2025,
author = {Zhang, Siqi and Hu, Jie and Qi, Zhigang and Yao, Chenyang and Cui, Bixiao and Wang, Jingjuan and Wang, Zhenming and Lu, Jie},
title = {Hybrid PET / MRI Imaging of 18F ‐Fluorodeoxyglucose and 18‐ kDa Translocator Protein for Presurgical Localization in Refractory Epilepsy},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70251}
}
EUVIMED